Mechanisms of Bioactivities of Fucoidan from the Brown Seaweed <i>Fucus vesiculosus</i> L. of the Barents Sea

Mechanisms of Bioactivities of Fucoidan from the Brown Seaweed <i>Fucus vesiculosus</i> L. of the Barents Sea

The aim of this study was to elucidate some mechanisms of radical scavenging and the anti-inflammatory, anti-hyperglycemic, and anti-coagulant bioactivities of high molecular weight fucoidan from <i>Fucus vesiculosus</i> in several in vitro models. Fucoidan has displayed potent 1, 1-diph...

Full description

Bibliographic Details
Main Authors:	Olga N. Pozharitskaya, Ekaterina D. Obluchinskaya, Alexander N. Shikov
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	Marine Drugs
Subjects:	fucoidan cyclooxygenase dipeptidyl peptidase IV anti-inflammatory anti-hyperglycemic anti-coagulant
Online Access:	https://www.mdpi.com/1660-3397/18/5/275

Similar Items

Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats
by: Olga N. Pozharitskaya, et al.
Published: (2018-04-01)

Bioactivity and chemical characterization of gonads of green sea urchin Strongylocentrotus droebachiensis from Barents Sea
by: Olga N. Pozharitskaya, et al.
Published: (2015-08-01)

Antibacterial Properties of Fucoidans from the Brown Algae <i>Fucus vesiculosus</i> L. of the Barents Sea
by: Olga N. Ayrapetyan, et al.
Published: (2021-01-01)

Fucoidan from Fucus vesiculosus suppresses hepatitis B virus replication by enhancing extracellular signal-regulated Kinase activation
by: Huifang Li, et al.
Published: (2017-09-01)

STUDIES ON FUCOIDAN AND ITS PRODUCTION FROM VIETNAMESE BROWN SEAWEEDS
by: Bui Minh Ly, et al.
Published: (2017-11-01)

Anti-diabetic potential of Urena lobata leaf extract through inhibition of dipeptidyl peptidase IV activity
by: Yudi Purnomo, et al.
Published: (2015-08-01)

Fucoidan from Fucus vesiculosus Protects against Alcohol-Induced Liver Damage by Modulating Inflammatory Mediators in Mice and HepG2 Cells
by: Jung Dae Lim, et al.
Published: (2015-02-01)

Soybean- and Lupin-Derived Peptides Inhibit DPP-IV Activity on In Situ Human Intestinal Caco-2 Cells and Ex Vivo Human Serum
by: Carmen Lammi, et al.
Published: (2018-08-01)

Micro RNA Expression after Ingestion of Fucoidan; A Clinical Study
by: Nuri Gueven, et al.
Published: (2020-02-01)

Dipeptidyl peptidase IV and its implication in cancer
by: Yarini M Arrebola, et al.

The durability of sitagliptin in elderly patients with type 2 diabetes
by: Hsieh CJ, et al.
Published: (2014-11-01)

Anti-Photoaging and Anti-Melanogenesis Effects of Fucoidan Isolated from <i>Hizikia fusiforme</i> and Its Underlying Mechanisms
by: Lei Wang, et al.
Published: (2020-08-01)

Low-molecular-weight fucoidan and high-stability fucoxanthin from brown seaweed exert prebiotics and anti-inflammatory activities in Caco-2 cells
by: Pai-An Hwang, et al.
Published: (2016-08-01)

Fucoidans as a natural bioactive ingredient for functional foods
by: Thanh-Sang Vo, et al.
Published: (2013-01-01)

Physicochemical and Biological Characterization of Fucoidan from Fucus vesiculosus Purified by Dye Affinity Chromatography
by: Ahmed Zayed, et al.
Published: (2016-04-01)

Fucoidan Content in Philippine Brown Seaweeds
by: Joemark T. Narsico, et al.
Published: (2018-06-01)

Antioxidant complex extracts from fucus algae of the Barents Sea
by: Obluchinskaya E. D.
Published: (2018-09-01)

Immunoadjuvant Activity of Fucoidans from the Brown Alga <i>Fucus evanescens</i>
by: Tatyana A. Kuznetsova, et al.
Published: (2020-03-01)

Therapeutic Effects of Fucoidan: A Review on Recent Studies
by: Sibusiso Luthuli, et al.
Published: (2019-08-01)

Fabrication and Cytotoxicity of Fucoidan-Cisplatin Nanoparticles for Macrophage and Tumor Cells
by: Pai-An Hwang, et al.
Published: (2017-03-01)

Fucoidan Derived from <i>Fucus vesiculosus</i> Inhibits the Development of Human Ovarian Cancer via the Disturbance of Calcium Homeostasis, Endoplasmic Reticulum Stress, and Angiogenesis
by: Hyocheol Bae, et al.
Published: (2020-01-01)

Oral Fucoidan Attenuates Lung Pathology and Clinical Signs in a Severe Influenza a Mouse Model
by: Claire Richards, et al.
Published: (2020-05-01)

Water Extraction Kinetics of Bioactive Compounds of <i>Fucus vesiculosus</i>
by: Ricardo M. Ferreira, et al.
Published: (2019-09-01)

Bullous Pemphigoid Triggered by Thermal Burn Under Medication With a Dipeptidyl Peptidase-IV Inhibitor: A Case Report and Review of the Literature
by: Yosuke Mai, et al.
Published: (2018-04-01)

Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-β1/Smad pathway-mediated inhibition of extracellular matrix and autophagy
by: Li J, et al.
Published: (2016-02-01)

A case of anti-BP230 antibody-positive bullous pemphigoid receiving DPP-4 inhibitor
by: Kaori Sawada, et al.
Published: (2021-01-01)

Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis
by: Jung Min Lee, et al.
Published: (2019-10-01)

Fucoidan Isolated from <i>Saccharina japonica</i> Inhibits LPS-Induced Inflammation in Macrophages via Blocking NF-κB, MAPK and JAK-STAT Pathways
by: Jing Ye, et al.
Published: (2020-06-01)

Fucoidan-Based Theranostic Nanogel for Enhancing Imaging and Photodynamic Therapy of Cancer
by: Mi Hyeon Cho, et al.
Published: (2020-02-01)

The Effect of Bioactive Polyphenols from <i>Anacardium occidentale</i> Linn. Leaves on α-Amylase and Dipeptidyl Peptidase IV Activities
by: Nur Imanina Abdullah Thaidi, et al.
Published: (2020-07-01)

The role of respiratory failure caused by congenital central nervous system abnormalities and the effect of β-casomorphins in sudden infant death syndrome pathogenesis
by: Barbara Sumińska-Ziemann, et al.
Published: (2015-08-01)

Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database
by: Sunghwan Suh, et al.
Published: (2015-06-01)

Anti-tumour activities of fucoidan from the aquatic plant Utricularia aurea lour
by: Wilaiwan Chotigeat, et al.
Published: (2005-12-01)

Anti-Metabolic Syndrome Effects of Fucoidan from <i>Fucus vesiculosus</i> via Reactive Oxygen Species-Mediated Regulation of JNK, Akt, and AMPK Signaling
by: Xueliang Wang, et al.
Published: (2019-09-01)

Synthesis and evaluation of novel spiro derivatives for pyrrolopyrimidines as anti-hyperglycemia promising compounds
by: Samar Said Fatahala, et al.
Published: (2018-01-01)

Management of diabetic kidney disease: Recent advances
by: Pankaj Agarwal
Published: (2013-01-01)

Fucoidan as bio-functional molecule: Insights into the anti-inflammatory potential and associated molecular mechanisms
by: Abdul Rehman Phull, et al.
Published: (2017-11-01)

FUCOIDAN FROM BROWN SEAWEED AND ITS BIOACTIVITY
by: Ellya Sinurat, et al.
Published: (2013-05-01)

Fucoidan from Fucus vesiculosus attenuates doxorubicin-induced acute cardiotoxicity by regulating JAK2/STAT3-mediated apoptosis and autophagy
by: Jie Zhang, et al.
Published: (2020-10-01)

Enhancement of Immune Checkpoint Inhibitor-Mediated Anti-Cancer Immunity by Intranasal Treatment of <i>Ecklonia cava</i> Fucoidan against Metastatic Lung Cancer
by: Wei Zhang, et al.
Published: (2021-08-01)